Literature DB >> 8883899

Mechanisms of glutamate and aspartate release in the ischemic rat cerebral cortex.

J W Phillis1, M H O'Regan.   

Abstract

Elevated levels of glutamate and aspartate have been implicated in the pathogenesis of neural injury and death induced by ischemia. The mechanism(s) whereby they escape into the extracellular environment have been a subject of controversy. This study evaluated the contribution of phospholipases and protein kinases to ischemia-evoked glutamate and aspartate release from the ischemic/reperfused rat cerebral cortex. Changes in the extracellular levels of these amino acids during four-vessel occlusion elicited global cerebral ischemia were examined using a cortical cup technique. Ischemia-evoked amino acid release was compared in control vs. drug treated animals, in which selective inhibitors of phospholipases and protein kinases were applied topically onto the cerebral cortex. The phospholipase inhibitors tested included 4-bromophenacyl bromide, a non-selective inhibitor; 7,7-dimethyleicosadienoic (DEDA), an inhibitor of secretory type phospholipase A2 (PLA2); AACOCF3, an inhibitor of the Ca2(+)-dependent cytoplasmic form of PLA2, HELSS, which inhibits a Ca(2+)-independent cytoplasmic PLA2, and U73122, a selective inhibitor of phospholipase C (PLC). All five phospholipase inhibitors significantly attenuated glutamate and aspartate release into the extracellular milieu, indicating the possibility that several forms of the enzyme are likely to be involved. The protein kinase C (PKC) inhibitor, chelerythrine chloride, also reduced excitatory amino acid efflux, wheres the PKC activator phorbol 12-myristate 13-acetate (PMA) enhanced their release. The non-selective kinase inhibitor, staurosporine, and H-89, which selectively inhibits protein kinase A, did not reduce ischemia-evoked amino acid efflux. These results suggest that ischemia-evoked release of the excitatory transmitters amino acids is a result, in part, of the activation of phospholipases A2 and C, with PKC involvement in the transduction process. Destabilization and deterioration of the plasma membrane, as a consequence of phospholipid hydrolysis, may allow these transmitter amino acids to diffuse down their concentration gradients into the extracellular fluid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883899     DOI: 10.1016/0006-8993(96)00434-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  17beta-estradiol effect on the extracellular concentration of amino acids in the glutamate excitotoxicity model in the rat.

Authors:  Marie-Françoise Ritz; Petra Schmidt; Aminadav Mendelowitsch
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

Review 2.  Volume-regulated anion channel--a frenemy within the brain.

Authors:  Alexander A Mongin
Journal:  Pflugers Arch       Date:  2015-12-01       Impact factor: 3.657

3.  Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain.

Authors:  V L Rao; A Dogan; K G Todd; K K Bowen; B T Kim; J D Rothstein; R J Dempsey
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Characterization of endogenous amino acid efflux from hippocampal slices during chemically-induced ischemia.

Authors:  S Djali; L A Dawson
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

5.  Alteration of phosphoinositide degradation by cytosolic and membrane-bound phospholipases after forebrain ischemia-reperfusion in gerbil: effects of amyloid beta peptide.

Authors:  J Strosznajder; A Zambrzycka; M D Kacprzak; D Kopczuk; R P Strosznajder
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

Review 6.  Signaling events during swelling and regulatory volume decrease.

Authors:  H Pasantes-Morales; V Cardin; K Tuz
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

7.  Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats.

Authors:  Nai-Kui Liu; William Lee Titsworth; Yi Ping Zhang; Aurela I Xhafa; Christopher B Shields; Xiao-Ming Xu
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

Review 8.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice.

Authors:  Koji Kishimoto; Rung-Chi Li; Jian Zhang; Judith A Klaus; Kathleen K Kibler; Sylvain Doré; Raymond C Koehler; Adam Sapirstein
Journal:  J Neuroinflammation       Date:  2010-07-30       Impact factor: 8.322

10.  Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat.

Authors:  Md Nasrul Hoda; Inderjit Singh; Avtar K Singh; Mushfiquddin Khan
Journal:  J Neuroinflammation       Date:  2009-08-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.